BETASERC Tablet

Betahistine Dihydrochloride

16 mg

BAXTER HEALTHCARE CORPORATION

Pack size	40's Pack
Dispensing mode
Source
Agent
Retail Price	1.26 AED

Available as:

8 mg - Tablet 24 mg - Tablet

Indications

BETASERC Tablet is used for: Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.

Adult Dose

Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.

Child Dose

Renal Dose

Administration

Should be taken with food.

Contra Indications

Phaeochromocytoma. Porphyria.

Precautions

Active peptic ulcer, bronchial asthma, pregnancy and lactation.

Pregnancy-Lactation

Interactions

May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.

Adverse Effects

Side effects of Betahistine Dihydrochloride : Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.

Mechanism of Action

Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.

Note

BETASERC 16 mg Tablet manufactured by BAXTER HEALTHCARE CORPORATION. Its generic name is Betahistine Dihydrochloride. BETASERC is availble in Saudi Arabia. Farmaco SA drug index information on BETASERC Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Betahistine Dihydrochloride :

Tablet

BERTIGO ^{8 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Tablet

BERTIGO ^{24 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Tablet

BERTIGO ^{16 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

BAXTER HEALTHCARE CORPORATION